Viewing Study NCT06374394


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2025-12-26 @ 2:31 AM
Study NCT ID: NCT06374394
Status: COMPLETED
Last Update Posted: 2025-05-23
First Post: 2024-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 217848
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators